Pancreatic Cancer Research

ResearcherCedars-Sinai Medical CenterActive in the last 2 years

Omer Hany Miligy Elmadbouh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6912-1594; OpenAlex author ID A5059458080. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2022: 2 papers · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 7

  1. L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 Glut… Co-author DOI 10.1038/s43018-026-01225-z↗
  2. HDAC4/MybL1/YAP novel signaling axis is required for pancreatic cancer metastasis to the liver. First author DOI 10.7150/ijbs.102132↗
  3. Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells. Co-author DOI 10.1016/j.freeradbiomed.2024.01.003↗
  4. Evaluation of the toxicity of Caralluma europaea (C.E) extracts and their effects on apoptosis and chemoresistance in pancreatic cancer cells. First author DOI 10.1080/07391102.2022.2135595↗
  5. Supraphysiological glutamine as a means of depleting intracellular amino acids to enhance pancreatic cancer chemosensitivity Co-author DOI 10.21203/rs.3.rs-3647514/v1↗
  6. Novel DZ-SIM Conjugate Targets Cancer Mitochondria and Prolongs Survival in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/adtp.202200021↗
  7. Glycogen Synthase Kinase 3β: A True Foe in Pancreatic Cancer. Co-author DOI 10.3390/ijms232214133↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mouad Edderkaoui · 7 shared papers, 2022–2026 · strength 1.38
  2. Stephen Jacob Pandol · 6 shared papers, 2022–2026 · strength 1.21
  3. Arsen Osipov · 3 shared papers, 2024–2026 · strength 0.64
  4. Neil A. Bhowmick · 3 shared papers, 2023–2026 · strength 0.59
  5. Raul A. Urrutia · 2 shared papers, 2024–2025 · strength 0.42
  6. Andrew Eugene Hendifar · 2 shared papers, 2023–2026 · strength 0.37
  7. Hayato Muranaka · 2 shared papers, 2023–2026 · strength 0.37
  8. Jun Gong · 2 shared papers, 2023–2026 · strength 0.37
  9. Yan Ou · 2 shared papers, 2022–2025 · strength 0.37
  10. Dina Hauptschein · 1 shared paper, 2025 · strength 0.21
  11. Ramachandran Murali · 1 shared paper, 2025 · strength 0.21
  12. Tao Liu · 1 shared paper, 2024 · strength 0.21
  13. Qiang Wang · 1 shared paper, 2024 · strength 0.21
  14. Wei Jie Zhou · 1 shared paper, 2024 · strength 0.21
  15. Dalila Bousta · 1 shared paper, 2023 · strength 0.17
  16. Fatima Ez‐Zahra Amrati · 1 shared paper, 2023 · strength 0.17
  17. Yi Zhang · 1 shared paper, 2022 · strength 0.16
  18. Ruoxiang Wang · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.